News

The new AED40m ($10.8m) manufacturing facility will mark the company’s expansion into growing regional pharmaceutical markets while signalling the first pharmaceutical production unit at DuBiotech. The90,000ft² facility is

Raptor has appealed for priority review of the NDA, which, if granted, could lead to a decision for marketing approval of RP103 in the fourth calendar quarter of

The partnership is aimed at identifying biomarkers that may lead to the development of a molecular companion diagnostic test to help identify patients likely to respond to a

Threshold is presently testing TH-302 along with a commonly used chemotherapeutic agent, doxorubicin, in a late-stage trial to treat soft tissue sarcoma. The orphan status can provide a

Accuray and the University of Heidelberg will join forces on radiation oncology research to progress treatment technology. Accuray president and chief executive officer Euan Thomson said: "As the

The study will evaluate the safety and pharmacokinetics of rVIIa-FP in comparison to placebo, in healthy volunteers. Due to albumin’s inherently long half-life, high potential for tolerability, known

Clotamin is an over-the-counter multivitamin product designed for use by patients on Warfarin or other anticoagulants (blood thinners). Sunpeaks CEO Mackie A. Barch said: "Moving forward, we believe

MemberMATCH solution is designed to centralize critical data sources, reducing and eliminating manual processing, thereby increasing compliance. The MemberMATCH membership automation solution also provides key functions, including a

The DosePro system is designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle. DosePro needle-free system delivers larger dose viscous drug formulations